Primary Site >> Colorectal Cancer
Gene >> SERPINB2
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Ref: Inhibition of cancer cell urokinase plasminogen activator by its specific inhibitor PAI-2 and subsequent effects on extracellular matrix degradation. PMID: 2114945 Ref: Insensitivity of laminin degradation directed by receptor bound urokinase to PAI-1 in cultured colon cancer. PMID: 2390419 |
Ref: Plasminogen activator inhibitor in stomach and colorectal carcinomas. PMID: 1796298 Ref: Plasminogen activator inhibitor 1 in human carcinoma tissues. PMID: 1904404 |
Ref: The role of the urokinase receptor in extracellular matrix degradation by HT29 human colon carcinoma cells. PMID: 8381394 Ref: Plasminogen activators and plasminogen activator inhibitors in human colorectal carcinoma tissues are not expressed by the tumour cells. PMID: 8518031 |
Ref: Expression and release of plasminogen activators, their inhibitors and receptor by human tumor cell lines. PMID: 7872665 Ref: Chromosomal localization of the human urokinase plasminogen activator receptor and plasminogen activator inhibitor type-2 genes: implications in colorectal cancer. PMID: 7948815 Ref: Human Co115 colon carcinoma cells potentiate the degradation of laminin mediated by tissue-type plasminogen activator. PMID: 7962113 Ref: Prognostic relevance of plasminogen activators and their inhibitors in colorectal cancer. PMID: 8033138 |
Ref: Antigen levels of urokinase plasminogen activator and its receptor at the tumor-host interface of colorectal adenocarcinomas are related to tumor aggressiveness. PMID: 7557947 Ref: Localization of urokinase-type plasminogen activator, plasminogen activator inhibitor-1, 2 and plasminogen in colon cancer. PMID: 7737909 |
Ref: Fibrinolysis components as prognostic markers in breast cancer and colorectal carcinoma. PMID: 8694536 |
Ref: Contribution of plasminogen activators and their inhibitors to the survival prognosis of patients with Dukes' stage B and C colorectal cancer. PMID: 9192984 |
Ref: [Assay and detection methods for urokinase-type plasminogen activator and its related-factors]. PMID: 10396332 Ref: Larger and more invasive colorectal carcinoma contains larger amounts of plasminogen activator inhibitor type 1 and its relative ratio over urokinase receptor correlates well with tumor size. PMID: 10594855 |
Ref: Urokinase-type plasminogen activator and its receptor in colorectal cancer: independent prognostic factors of metastasis and cancer-specific survival and potential therapeutic targets. PMID: 11008205 Ref: Plasminogen activator system, vascular endothelial growth factor, and colorectal cancer progression. PMID: 11193049 |
Ref: Urokinase receptor and vascular endothelial growth factor are synergistically associated with the liver metastasis of colorectal cancer. PMID: 11376560 Ref: In vitro and preclinical targeted alpha therapy for melanoma, breast, prostate and colorectal cancers. PMID: 11418311 |
Ref: High tumor tissue concentration of plasminogen activator inhibitor 2 (PAI-2) is an independent marker for shorter progression-free survival in patients with early stage endometrial cancer. PMID: 11774293 Ref: Plasmin/plasminogen system in colorectal cancer. PMID: 11965442 Ref: Cyclooxygenase-2 expression correlates with uPAR levels and is responsible for poor prognosis of colorectal cancer. PMID: 12405290 |
Ref: Quantitative expression of protein markers of plasminogen activation system in prognosis of colorectal cancer. PMID: 12619063 |
Ref: NS-398 inhibits tumor growth and liver metastasis of colon cancer through induction of apoptosis and suppression of the plasminogen activation system in a mouse model. PMID: 15325613 |
Ref: Effect of NS398 on metastasis-associated gene expression in a human colon cancer cell line. PMID: 16038031 Ref: Association of interleukin-8 and plasminogen activator system in the progression of colorectal cancer. PMID: 16088182 |
Ref: Different matrix micro-environments in colon cancer and diverticular disease. PMID: 17021746 |
Ref: Intraperitoneal infusion of recombinant plasminogen activator inhibitor type 2 induced apoptosis in implanted human colon cancer and inhibited its growth and liver metastasis. PMID: 18507009 |
Ref: Clinical significance of the plasminogen activator system in relation to grade of tumor and treatment response in colorectal carcinoma patients. PMID: 21744990 Ref: Clinical relevance of uPA, uPAR, PAI 1 and PAI 2 tissue expression and plasma PAI 1 level in colorectal carcinoma patients. PMID: 22234062 |